Genenta Science S p A : Consolidated Statements of Operations and Comprehensive Loss - Form 6-K -October 20, 2023 at 04:55 pm EDT

Genenta Science S.p.A.


Consolidated Statements of Operations and Comprehensive Loss








Six Months Ended June...

Related Keywords

Russia ,United States ,Delaware ,Milan ,Lombardia ,Italy ,Bresso ,Ukraine ,America ,Italian ,Bernhard Gentner ,Richard Slansky ,Carlo Russo ,Imposta Sul Valore Aggiunto ,Institut Pasteur ,Pierluigi Paracchi ,Raffaele Hospitalas ,Bernard Rudolph Gentner ,Luigi Naldini ,Manufacturing Service Agreement ,Company Of Theravecty ,Master Service Agreement ,Head Of Development ,Company Board Of Directors The ,Framework Service Agreement ,Company Equity Incentive Plan ,Glaxosmithkline Intellectual Property Development ,European Commission ,International Accounting Standards ,Cantor Fitzgerald Co ,Company Is Euros ,Research Agreementon ,Exchange Commission ,Genenta Science Inc ,Company At ,Company Annual ,Nasdaq ,Research Agreement ,Company Consolidated Statements Of Operations ,Company Annual Report On Form ,Company Or Genenta ,Investment Company ,Months Ended June ,Consolidated Financial ,San Raffaele Hospital ,Genenta Science ,Nasdaq Stock Capital Market ,Depository Shares ,Controlled Equity ,Cantor Fitzgerald ,Sales Agreement ,Renal Cell Cancer ,Investment Company Act ,Regulations X ,Accounting Standards Codification ,Accounting Standards Update ,Financial Accounting Standards Board ,Annual Report ,Equity Incentive Plan ,Consolidated Statements ,Jumpstart Our Business Startups Act ,Government Grants ,Incentive Plan ,Consolidated Statement ,Comprehensive Loss ,Income Taxes ,Government Assistance ,Business Entities ,Own Equity ,Convertible Instruments ,Related Parties ,Valore Aggiunto ,Fine Rapporto ,Consumer Price Index ,Benefits The ,Black Scholes ,Average Remaining Contractual Term ,Raffaele Hospital ,Rudolph Gentner ,Chief Medical Officer ,Chief Financial Officer ,San Raffaele ,Chief Executive Officer ,Scientific Advisory Board ,License Agreement ,Law Decree ,Italian Golden Power ,Adoption Fee ,Royalty Term ,Side Letter ,Process Transfer Agreement ,Tech Transfer ,Research Agreementon August ,Sponsored Research Agreement ,Candidate Products ,Markets ,